Measuring objective and subjective sleep during lisdexamfetamine treatment of acute methamphetamine withdrawal: a feasibility study

Liam S. Acheson*, Christopher Gordon, Rebecca McKetin, Jonathan Brett, Michael Christmass, Craig Rodgers, Nicholas Lintzeris, Adrian Dunlop, Michael Farrell, Steven Shoptaw, Nadine Ezard, Krista J. Siefried

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Downloads (Pure)

Abstract

Introduction: Sleep disturbance is common during methamphetamine (MA) use and withdrawal; however, the feasibility of combined subjective-objective measurement of sleep-wake has not been shown in this population. Actigraphy is a well-established, non-invasive measure of sleep-wake cycles with good concordance with polysomnography. This study aimed to investigate the feasibility and utility of using actigraphy and sleep diaries to investigate sleep during MA withdrawal. Methods: We conducted a feasibility and utility study of actigraphy and sleep diaries during a clinical trial of lisdexamfetamine for MA withdrawal. Participants were inpatients for 7 days, wore an actigraph (Philips Actiwatch 2) and completed a modified Consensus Sleep Diary each morning. Participants were interviewed between days 3-5. Results: Ten participants (mean age 37 years, 90% male) were enrolled. No participant removed the device prematurely. Participants interviewed (n = 8) reported that the actigraph was not difficult or distracting to wear or completion of daily sleep diary onerous. Actigraphic average daily sleep duration over 7 days was 568 min, sleep onset latency 22.4 min, wake after sleep onset (WASO) 75.2 min, and sleep efficiency 83.6%. Sleep diaries underreported daily sleep compared with actigraphy (sleep duration was 56 min (p = 0.008) and WASO 47 min (p < 0.001) less). Overall sleep quality was 4.4 on a nine-point Likert scale within the diary. Conclusions: Continuous actigraphy is feasible to measure sleep-wake in people withdrawing from MA, with low participant burden. We found important differences in self-reported and actigraphic sleep, which need to be explored in more detail.

Original languageEnglish
Pages (from-to)121-125
Number of pages5
JournalEuropean Addiction Research
Volume30
Issue number2
DOIs
Publication statusPublished - Apr 2024
Externally publishedYes

Bibliographical note

Copyright the Author(s) 2024. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • Feasibility
  • Measurement
  • Methamphetamine
  • Sleep
  • Withdrawal

Fingerprint

Dive into the research topics of 'Measuring objective and subjective sleep during lisdexamfetamine treatment of acute methamphetamine withdrawal: a feasibility study'. Together they form a unique fingerprint.

Cite this